A cost-effectiveness analysis of stays in intensive care units

Intensive Care Medicine

Volumn 27, Issue 1, 2001, Pages 146-153

  Sznajder, M ^a   Aegerter, P ^a   Launois, R ^b   Merliere, Y ^c   Guidet, B ^d   Cub, R ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Cost benefit analysis; EuroQol; Healthcare costs; Hospital costs; Intensive care; Quality adjusted life years; Resource allocation

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION;

ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HEALTH CARE RATIONING; HOSPITAL COSTS; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PARIS; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY;

EID: 0035090911     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000760     Document Type: Article

References (33)

1. A review of cost studies of intensive care units: Problems with the cost concept
2. Intensive care unit patient follow-up mortality, functional status and return to work
3. Mortality and quality of life after intensive care for critical illness
4. Quality of life 6 months after intensive care: Results of a prospective multieenter study using a generic health status scale and a satisfaction scale
5. A new simplified acute physiology score (SAPS II) based on a Euxopean/North American multicenter study
6. Why severity scores should be used with caution
7. A cost-utility analysis of intensive care
8. The use of "quality-adjusted life years" (OALYs) to evaluate treatment in intensive care
9. Mise en oeuvre et évaluation d'une base de donntes commune aux services de réanimation d'lle-de-France
10. Estimation of direct cost and resource allocation in intensive care: Correlation with Omega system
11. Gram negative bacteriemia: Etiology and ecology
12. EuroQol: The current state of play
13. The role of cost-effectiveness analysis in health and medicine
14. Long-term survival after intensive care
15. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
16. Variations in population health status: Results from a United Kingdom national questionnaire survey
17. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: A cost-effectiveness analysis
18. Treatment costs in Hodgkin disease: A costutility analysis
19. Is it "worthwhile" to continue treating patients with a prolonged stay (> 14 days) in the ICU? An economic evaluation
20. Use of intensive care units for patients with low severity of illness
21. Costing intensive care services: A review of study methods, results and limitations
22. A model to compute the medical cost of patients in intensive care
23. Cost accounting of adult intensive care: Methods and human and capital inputs
24. Prolonged mechanical ventilation for respiratory failure: A cost-benefit analysis
25. Measuring health and health state preferences among critically ill patients
26. The cost-effectiveness of lung transplantation
27. Cost-effectiveness of detecting and treating diabetic retinopathy
28. Cost-effectiveness of vaccination against pneumoeoeeal bacteremia among elderly people
29. Factors related to quality of life twelve months after discharge from an intensive care unit
30. An evaluation of the impact of nonresponse bias on patient satisfaction surveys
31. Quality of life after intensive care with the sickness impact profile
32. Use of the EuroQol among el-Y derly acute care patients